Futura Medical PLC Total Voting Rights (6128G)
31 May 2017 - 4:00PM
UK Regulatory
TIDMFUM
RNS Number : 6128G
Futura Medical PLC
31 May 2017
31 May 2017
Futura Medical plc
("Futura" or "the Company")
Total Voting Rights
As at the date of this announcement, the Company's issued share
capital consists of 120,658,682 ordinary shares with a nominal
value of 0.2 pence each ("Ordinary Shares"), each carrying one
voting right.
The Company does not hold any Ordinary Shares in Treasury.
Therefore, the total number of voting rights is 120,658,682.
The above figure of 120,658,682 Ordinary Shares may be used by
shareholders in the Company as the denominator for the calculations
by which they will determine if they are required to notify their
interest in, or a change in their interest in, the share capital of
the Company under the FCA's Disclosure and Transparency Rules.
For further information please contact:
Futura Medical plc
James Barder, Chief Executive Tel: +44 (0) 1483
685 670
Email to: james.barder@futuramedical.com www.futuramedical.com
N+1 Singer (Nominated Adviser
and Broker)
Aubrey Powell / Liz Yong Tel:+44 (0) 20 7496
Corporate Finance 3000
For media enquiries please
contact:
Buchanan
Mark Court / Sophie Cowles Tel: +44 (0) 20 7466
/ Stephanie Watson 5000
Notes to Editors
Futura Medical plc
Futura Medical is a pharmaceutical group that develops
innovative products for consumer healthcare. The Company is
developing a portfolio of products and its strategy is to license
their manufacture and distribution to major pharmaceutical and
healthcare groups.
Futura is based in Guildford, Surrey, and its shares trade on
the AIM market of the London Stock Exchange.
www.futuramedical.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
TVRGMGFKVGRGNZM
(END) Dow Jones Newswires
May 31, 2017 02:00 ET (06:00 GMT)
Futura Medical (LSE:FUM)
Historical Stock Chart
From Apr 2024 to May 2024
Futura Medical (LSE:FUM)
Historical Stock Chart
From May 2023 to May 2024
